Proposal
Proposal
Search
Search
Ctrl+K
Publish
Home
Fund
Earn
Journal
Notebook
Lists
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
AI-Driven Repurposing of FDA-Approved Compounds for Preci... | ResearchHub
AI-Driven Repurposing of FDA-Approved Compounds for Precision Neuroscience Therapeutics
By
Yassir Boulaamane
Yassir Boulaamane
February 13, 2026
1
Fund Proposal
Fund Proposal
Project
Updates
0
Conversation
0
Reviews
3.0
Bounties
0
Proposal
Proposal
Search
Search
Ctrl+K
Publish
Home
Fund
Earn
Journal
Notebook
Lists
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
Sign in to review
Share your thoughts on this paper...
Best
Funding Progress
0%
/
1K
Contributors
0
Status
OPEN
Nonprofit Recipient
Peer Reviews
CL
Chieh-Te Lin
about 1 month ago
CL
Chieh-Te Lin
about 1 month ago
Topics
#computational-chemistry
#drug-repositioning
#cheminformatics
DOI
10.55277/researchhub.13ymy5ro
Funding Progress
0%
/
1K
Contributors
0
Status
OPEN
Nonprofit Recipient
Peer Reviews
CL
Chieh-Te Lin
about 1 month ago
CL
Chieh-Te Lin
about 1 month ago
Topics
#computational-chemistry
#drug-repositioning
#cheminformatics
DOI
10.55277/researchhub.13ymy5ro
